BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33777482)

  • 1. Initial Experience in Monitoring QT Intervals Using a Six-lead Contactless Mobile Electrocardiogram in an Inpatient Setting.
    Frisch DR; Frankel ES; Farzad DJ; Woo SH; Kubey AA
    J Innov Card Rhythm Manag; 2021 Mar; 12(3):4433-4440. PubMed ID: 33777482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device.
    Giudicessi JR; Schram M; Bos JM; Galloway CD; Shreibati JB; Johnson PW; Carter RE; Disrud LW; Kleiman R; Attia ZI; Noseworthy PA; Friedman PA; Albert DE; Ackerman MJ
    Circulation; 2021 Mar; 143(13):1274-1286. PubMed ID: 33517677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients.
    Zaballos M; Fernández I; Rodríguez L; Orozco S; García A; Juncos M; Alvarez-Zaballos S; Piñeiro P; Hortal J
    Sci Rep; 2023 Jul; 13(1):10985. PubMed ID: 37415069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of mobile 6-lead electrocardiogram device for assessment of QT interval: a prospective validation study.
    Bergeman AT; Pultoo SNJ; Winter MM; Somsen GA; Tulevski II; Wilde AAM; Postema PG; van der Werf C
    Neth Heart J; 2023 Sep; 31(9):340-347. PubMed ID: 36063313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manual QT interval measurement with a smartphone-operated single-lead ECG versus 12-lead ECG: a within-patient diagnostic validation study in primary care.
    Beers L; van Adrichem LP; Himmelreich JCL; Karregat EPM; de Jong JSSG; Postema PG; de Groot JR; Lucassen WAM; Harskamp RE
    BMJ Open; 2021 Nov; 11(11):e055072. PubMed ID: 34732504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6-lead mobile ECG device and a standard 12-lead ECG.
    Kleiman R; Darpo B; Brown R; Rudo T; Chamoun S; Albert DE; Bos JM; Ackerman MJ
    Ann Noninvasive Electrocardiol; 2021 Nov; 26(6):e12872. PubMed ID: 34288227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portable single-lead electrocardiogram device is accurate for QTc evaluation in hospitalized patients.
    Marín O MM; García P ÁA; Muñoz V OM; Castellanos R JC; Cáceres M E; Santacruz P D
    Heart Rhythm O2; 2021 Aug; 2(4):382-387. PubMed ID: 34223287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison Between QT and Corrected QT Interval Assessment by an Apple Watch With the AccurBeat Platform and by a 12‑Lead Electrocardiogram With Manual Annotation: Prospective Observational Study.
    Chokshi S; Tologonova G; Calixte R; Yadav V; Razvi N; Lazar J; Kachnowski S
    JMIR Form Res; 2022 Sep; 6(9):e41241. PubMed ID: 36169999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of AliveCor KardiaMobile Six-Lead ECG with Standard ECG in Pediatric Patients.
    Girvin ZP; Silver ES; Liberman L
    Pediatr Cardiol; 2023 Mar; 44(3):689-694. PubMed ID: 36056945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QT Interval Monitoring with Handheld Heart Rhythm ECG Device in COVID-19 Patients.
    Minguito-Carazo C; Echarte-Morales J; Benito-González T; Del Castillo-García S; Rodríguez-Santamarta M; Sánchez-Muñoz E; Maniega CG; García-Bergel R; Menéndez-Suárez P; Prieto-González S; Palacios-Echavarren C; Borrego-Rodríguez J; Flores-Vergara G; Iglesias-Garriz I; Fernández-Vázquez F
    Glob Heart; 2021 Jun; 16(1):42. PubMed ID: 34211828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart devices to measure and monitor QT intervals.
    Hoek LJ; Brouwer JLP; Voors AA; Maass AH
    Front Cardiovasc Med; 2023; 10():1172666. PubMed ID: 38089772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Analysis of Hospital Electrocardiogram Auto-Populated QT Interval Calculation.
    Rosenblum AL; Dremonas AC; Stockholm SC; Biondi NL
    Cureus; 2020 Jul; 12(7):e9317. PubMed ID: 32714713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved accuracy and confidence with multiple-lead recordings from a single-lead mobile electrocardiographic device.
    Frisch DR; Weiss M; Dikdan SJ; Keith SW; Sarkar K
    Pacing Clin Electrophysiol; 2019 Sep; 42(9):1191-1196. PubMed ID: 31400010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. User Perceptions and Experiences of a Handheld 12-Lead Electrocardiographic Device in a Clinical Setting: Usability Evaluation.
    Wong KC; Thiagalingam A; Kumar S; Marschner S; Kunwar R; Bailey J; Kok C; Usherwood T; Chow CK
    JMIR Cardio; 2021 Aug; 5(2):e21186. PubMed ID: 34435958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification.
    Goldenberg I; Mathew J; Moss AJ; McNitt S; Peterson DR; Zareba W; Benhorin J; Zhang L; Vincent GM; Andrews ML; Robinson JL; Morray B
    J Am Coll Cardiol; 2006 Sep; 48(5):1047-52. PubMed ID: 16949500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide.
    Garabelli P; Stavrakis S; Albert M; Koomson E; Parwani P; Chohan J; Smith L; Albert D; Xie R; Xie Q; Reynolds D; Po S
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):827-32. PubMed ID: 27027653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Utility of Continuous QT Interval Monitoring in Patients Admitted With COVID-19 Compared With Standard of Care: A Prospective Cohort Study.
    Alqarawi W; Birnie DH; Golian M; Nair GM; Nery PB; Klein A; Davis DR; Sadek MM; Neilipovitz D; Johnson CB; Green MS; Redpath C
    CJC Open; 2020 Nov; 2(6):592-598. PubMed ID: 32838256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of lead adjustment formulas for QT dispersion after myocardial infarction.
    Glancy JM; Garratt CJ; Woods KL; de Bono DP
    Br Heart J; 1995 Dec; 74(6):676-9. PubMed ID: 8541177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
    Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
    J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.